- APhA Annual Meeting Activities
- Fifteen hours of nuclear pharmacy continuing
education credit available at the APhA Meeting in Seattle plus
many networking opportunities, including the NEO Luncheon, March 26 -
30, 2004. For a list of selected activities
- NANP Meeting:
State-of-the-Art and Beyond
National Association of Nuclear Pharmacies will hold a panel
discussion and industry forum on several cutting-edge legislative
and regulatory issues that impact the practice and operations of
nuclear pharmacies on March 28th during the APhA Meeting. For
more information about the meeting and the topics that will be
- Next Generation Stress Agent:
- Phase 3 trials were initiated in
December 2003 for a new pharmacologic stress agent, Binodenoson,
specific to the only adenosine receptor necessary for increased
cardiac blood flow, the A2A receptor. This specificity
allows Binodenoson to deliver - in a single injection - a more
effective dose of medication with fewer side effects.
- Medicare Solicits Public Input on
FDG for Alzheimer's
- The Centers for Medicare and
Medicaid Services (CMS) has updated the National Coverage Analysis
tracking sheet for PET(FDG) and Other Neuroimaging Devices for
Suspected Dementia. In this update, CMS is requesting input from the
public regarding questions they have developed after reviewing the
National Coverage Determination request for the use of PET in the
diagnosis of Alzheimer’s Disease and the Alzheimer’s Association
position statement on PET.
Responses are to be sent to Samantha
email@example.com by March 31, 2004
- Medical Dictionary Available
- Not sure what genual or nystagmus mean?
Check out the online
Medical Dictionary. For a traditional dictionary or
thesaurus at www.merriamwebster.com.
Comments or Suggestions?
Let us know your thoughts about the newsletter.
Greater New York Chapter SNMT,
APhA Annual Meeting in
NEO Luncheon on Saturday!
Southwest Chapter SNM,
Mid-Eastern Chapter SNM, Richmond, VA
Deadline for APhA Section Officer
SNM 51st Annual Meeting, Philadelphia, PA
FIP Annual Meeting,
New Orleans, LA
Nuclear Medicine Meeting, Helsinki, Finland
- © 2004 Nuclear Education Online
- 4301 W. Markham #522
- Little Rock, AR 72205
- For more information, contact
Brought to you by
"Radioactive Red" Fiestaware -the ingredient in
the glaze that makes it turn red (actually orange)
upon firing is uranium oxide, which is radioactive.
The color was discontinued in 1943 not because of
the radioactivity, but because the government
banned the use of uranium oxide during that time
for any other purpose than its own Manhattan
Project (the development of the atomic bomb!).
Acidic foods like vinegar and tomato sauce tend to
leach out and absorb uranium from the glaze, but in
1981 the U.S. Food and Drug Administration said
that the radioactivity levels of the plates was low
enough not to be a health hazard. That's well
enough, but it was later determined in 1994 that
the red pieces were also leaking radon gas through
cracks in the glaze at levels that are seven times
higher than is considered safe. So it's probably
best to stay away from those red plates, but only
those made before 1972. After that they started
using other ingredients to create that vibrant red.
A 44-year-old man came in for
evaluation of right upper quadrant pain. He has had numerous
episodes of this. His workup included an ultrasound which confirmed
chronic cholecystitis with no cholelithiasis. He was referred
to nuclear medicine for further evaluation.
To subscribe to this mailing list
email does not view graphics properly go to